Experience of adopting faecal immunochemical testing to meet the NICE colorectal cancer referral criteria for low-risk symptomatic primary care patients in Oxfordshire, UK
- 9 October 2018
- journal article
- research article
- Published by BMJ in Frontline Gastroenterology
- Vol. 10 (4) , 347-355
Abstract
Objective To compare the diagnostic performance of guaiac faecal occult blood (gFOB) testing with faecal immunochemical test (FIT) in a low-risk symptomatic primary care population to provide objective data on which to base local referral guidelines. Design Stool samples from routine primary care practice sent for faecal occult blood testing were analysed by a standard gFOB method and the HM-JACKarc FIT between January and March 2016. Symptoms described on the test request were recorded. Patients were followed up over 21 months for evidence of serious gastrointestinal pathology including colorectal adenocarcinoma. Results In 238 patients, the sensitivity and specificity for colorectal adenocarcinoma detection using gFOB were 85.7% and 65.8%, respectively, compared with 85.7% and 89.2% for FIT. The positive predictive value (PPV) for gFOB was 7.1% and negative predictive value (NPV) was 99.3%. Comparatively, the PPV for FIT was 19.4% and NPV 99.5%. The improved performance of FIT over gFOB was due to a lower false positive rate (10.8 vs 34.2, p≤0.01) with no increase in the false negatives rate. For any significant colorectal disease, the PPV for FIT increased to 35.5% with a reduction in NPV to 95.7%. Conclusion In this low-risk symptomatic patient group, the proportion of samples considered positive by FIT was considerably lower than gFOB with the same rate of colorectal adenocarcinoma detection. One in three of those with positive FIT had a significant colorectal disease. This supports National Institute of Health and Care Excellence recommendation that FIT can be reliably used as a triage test in primary care without overburdening endoscopy resources.Keywords
This publication has 21 references indexed in Scilit:
- Screening for Colorectal CancerJAMA, 2016
- Authors’ reply to Steele and colleaguesBMJ, 2015
- Use of faecal occult blood tests in symptomatic patientsBMJ, 2015
- Faecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptomsGut, 2015
- Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to knowGut, 2015
- PWE-019 An Evaluation Of Quantitative Faecal Immunochemical Tests For HaemoglobinGut, 2014
- The diagnostic value of symptoms for colorectal cancer in primary care: a systematic reviewBritish Journal of General Practice, 2011
- Value of symptoms and additional diagnostic tests for colorectal cancer in primary care: systematic review and meta-analysisBMJ, 2010
- Effect of delay in sampling on haemoglobin determined by faecal immunochemical testsAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2008
- THE GUAIACUM TEST FOR OCCULT BLOOD IN FÆCESThe Lancet, 1969